AU2003283174A1 - Method for protein production - Google Patents

Method for protein production

Info

Publication number
AU2003283174A1
AU2003283174A1 AU2003283174A AU2003283174A AU2003283174A1 AU 2003283174 A1 AU2003283174 A1 AU 2003283174A1 AU 2003283174 A AU2003283174 A AU 2003283174A AU 2003283174 A AU2003283174 A AU 2003283174A AU 2003283174 A1 AU2003283174 A1 AU 2003283174A1
Authority
AU
Australia
Prior art keywords
protein production
protein
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003283174A
Other versions
AU2003283174A8 (en
Inventor
Martin F. Bachmann
Frank Hennecke
Philippe Saudan
Dorothee M. Stern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytos Biotechnology AG
Original Assignee
Cytos Biotechnology AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytos Biotechnology AG filed Critical Cytos Biotechnology AG
Publication of AU2003283174A1 publication Critical patent/AU2003283174A1/en
Publication of AU2003283174A8 publication Critical patent/AU2003283174A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
AU2003283174A 2002-12-11 2003-12-10 Method for protein production Abandoned AU2003283174A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43224502P 2002-12-11 2002-12-11
US60/432,245 2002-12-11
PCT/CH2003/000810 WO2004053137A2 (en) 2002-12-11 2003-12-10 Method for protein production

Publications (2)

Publication Number Publication Date
AU2003283174A1 true AU2003283174A1 (en) 2004-06-30
AU2003283174A8 AU2003283174A8 (en) 2004-06-30

Family

ID=32507877

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003283174A Abandoned AU2003283174A1 (en) 2002-12-11 2003-12-10 Method for protein production

Country Status (2)

Country Link
AU (1) AU2003283174A1 (en)
WO (1) WO2004053137A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002074969A2 (en) 2001-01-26 2002-09-26 University Of Lausanne Matrix attachment regions and methods for use thereof
EP1644508A1 (en) 2003-07-11 2006-04-12 Cytos Biotechnology AG Gene expression system
DE10333675A1 (en) * 2003-07-24 2005-03-03 Aventis Pharma Deutschland Gmbh Perfusion method for the production of erythropoietin
SG147468A1 (en) 2003-10-24 2008-11-28 Selexis Sa High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences
JP2006121995A (en) * 2004-10-29 2006-05-18 Tokyo Medical & Dental Univ Ebna1 mutant
EP1833976A2 (en) 2004-12-03 2007-09-19 Xoma Technology Ltd. Methods and materials for expression of a recombinant protein
CN101341252B (en) 2005-10-28 2011-08-17 弗·哈夫曼-拉罗切有限公司 Protein expression in rodent cells
WO2010045659A1 (en) 2008-10-17 2010-04-22 American Gene Technologies International Inc. Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
EP3307894A4 (en) * 2015-06-10 2019-01-16 American Gene Technologies International, Inc. Non-integrating viral delivery system and methods of use thereof
WO2017123918A1 (en) 2016-01-15 2017-07-20 American Gene Technologies International Inc. Methods and compositons for the activation of gamma-delta t-cells
US10137144B2 (en) 2016-01-15 2018-11-27 American Gene Technologies International Inc. Methods and compositions for the activation of gamma-delta T-cells
EP3413926A4 (en) 2016-02-08 2019-10-09 American Gene Technologies International, Inc. Hiv vaccination and immunotherapy
US10767183B2 (en) 2016-03-09 2020-09-08 American Gene Technologies International Inc. Combination vectors and methods for treating cancer
WO2018009246A1 (en) 2016-07-08 2018-01-11 American Gene Technologies International Inc. Hiv pre-immunization and immunotherapy
EP3487507A4 (en) 2016-07-21 2020-04-08 American Gene Technologies International, Inc. Viral vectors for treating parkinson's disease
WO2018187231A2 (en) 2017-04-03 2018-10-11 American Gene Technologies International Inc. Compositions and methods for treating phenylketonuria

Also Published As

Publication number Publication date
WO2004053137A3 (en) 2004-08-12
AU2003283174A8 (en) 2004-06-30
WO2004053137A2 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
AU2003203090A1 (en) Method for distinguishing between protein variants
EP1430983B8 (en) Method for electrochemical shaping
AU2003216464A1 (en) Certification method for manufacturing process
AU2003252405A1 (en) Process for producing soy protein
AU2003287642A1 (en) Process for solubilizing protein
AU2003206898A1 (en) Method for rate matching
AU2003283174A1 (en) Method for protein production
AU2002952747A0 (en) Method for analysing peptides
AU2003278355A1 (en) Process
AU2003258070A1 (en) Electrodionization method
AU2003294691A1 (en) Method for producing leather
AU2003264657A1 (en) Method for designing peptides
AU2003236292A1 (en) Process for producing canthaxanthin
AU2003263161A1 (en) Method for making recombinant proteins
AU2003269047A1 (en) Method for making biochips
AU2003253813A1 (en) Method for colpoplasty
AU2003258622A1 (en) Method for the production of $g(b)-carotinoids
AU2003283271A1 (en) Method for producing cephalexin
AU2003267541A1 (en) Method for the production of substituted trifluoroethylenes
AU2003286092A1 (en) Method for producing insulated elements
AU2003224047A1 (en) Method for producing polyamides
AU2003281047A1 (en) Method for producing 2-deoxy-l-ribose
AU2003278535A1 (en) Histoscreen method
AU2003245879A1 (en) Method for the production of substituted trifluoroetylenes
AU2003263197A1 (en) Process

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase